Alpha-Lipoic Acid: The Antioxidant That Works Inside the Mitochondria

Alpha-lipoic acid (ALA) is a naturally occurring compound synthesised in small amounts by the human body and found in trace quantities in foods such as spinach, broccoli, and organ meats. It functions as a cofactor for several mitochondrial enzyme complexes involved in energy metabolism, and as an antioxidant with an unusual property: unlike most antioxidants, it is both water and fat soluble, allowing it to function in virtually every cellular compartment — including inside the mitochondrial membrane, where the majority of reactive oxygen species (ROS) are generated during energy production.

Mechanism of Action

ALA's primary role in mitochondrial metabolism is as a cofactor for the pyruvate dehydrogenase complex and the alpha-ketoglutarate dehydrogenase complex — two enzyme systems that are essential steps in the conversion of glucose and amino acids into ATP. Without adequate ALA, these metabolic pathways operate less efficiently.

As an antioxidant, ALA directly neutralises several reactive oxygen species and, importantly, regenerates other antioxidants including vitamins C and E and glutathione — the body's primary intracellular antioxidant. This 'antioxidant recycling' effect gives ALA a broader impact on oxidative balance than its direct scavenging activity alone would suggest.

Evidence for Metabolic Support

The most consistent clinical evidence for ALA relates to glucose metabolism and insulin sensitivity. A meta-analysis published in Obesity Reviews (2018) pooling data from 24 randomised controlled trials found that ALA supplementation significantly reduced fasting blood glucose, insulin levels, and HOMA-IR (a measure of insulin resistance) compared to placebo. The effect sizes were modest but consistent across studies.

The Dose Question

Clinical studies have used ALA doses ranging from 300mg to 1,800mg per day. The majority of metabolic benefit evidence comes from studies using 300–600mg daily, which is the range most commonly used in supplement formulations. Higher doses (600–1,200mg) have been used in studies of diabetic neuropathy, but these are therapeutic doses for a specific clinical condition and are not necessary for general metabolic support.

ALA and Mitochondrial Synergy

ALA's relevance within a mitochondrial support formulation is mechanistically coherent. While compounds like Urolithin A work by clearing damaged mitochondria through mitophagy, ALA supports the function of existing mitochondria by reducing the oxidative burden they operate under and maintaining the efficiency of key metabolic enzyme complexes. These are complementary rather than redundant mechanisms — one addresses mitochondrial renewal, the other supports mitochondrial function.

Safety and Tolerability

ALA has a well-established safety profile at doses up to 600mg per day. The most commonly reported side effects at higher doses are gastrointestinal — nausea, stomach discomfort — and these are typically dose-dependent and transient. ALA can lower blood glucose, so individuals on diabetes medication should consult their doctor before supplementing. It should be taken with food to minimise gastrointestinal effects.